Regulatory Role of Human AP-Endonuclease (APE1/Ref-1) in YB-1-Mediated Activation of the Multidrug Resistance Gene MDR1

REFERENCES

• Bargou, R. C., K. Jurchott, C. Wagener, S. Bergmann, S. Metzner, K. Bommert, M. Y. Mapara, K. J. Winzer, M. Dietel, B. Dorken, and H. D. Royer. 1997. Nuclear localization and increased levels of transcription factor YB-1 in primary human breast cancers are associated with intrinsic MDR1 gene expression. Nat. Med. 3:447–450.
   PubMed Web of Science ®Google Scholar
• Bhakat, K. K., T. Izumi, S. H. Yang, T. K. Hazra, and S. Mitra. 2003. Role of acetylated human AP-endonuclease (APE1/Ref-1) in regulation of the parathyroid hormone gene. EMBO J. 22:6299–6309.
   PubMed Web of Science ®Google Scholar
• Bhakat, K. K., S. K. Mokkapati, I. Boldogh, T. K. Hazra, and S. Mitra. 2006. Acetylation of human 8-oxoguanine-DNA glycosylase by p300 and its role in 8-oxoguanine repair in vivo. Mol. Cell. Biol. 26:1654–1665.
   PubMed Web of Science ®Google Scholar
• Bobola, M. S., L. S. Finn, R. G. Ellenbogen, J. R. Geyer, M. S. Berger, J. M. Braga, E. H. Meade, M. E. Gross, and J. R. Silber. 2005. Apurinic/apyrimidinic endonuclease activity is associated with response to radiation and chemotherapy in medulloblastoma and primitive neuroectodermal tumors. Clin. Cancer Res. 11:7405–7414.
   PubMed Web of Science ®Google Scholar
• Boeckman, H. J., K. S. Trego, and J. J. Turchi. 2005. Cisplatin sensitizes cancer cells to ionizing radiation via inhibition of nonhomologous end joining. Mol. Cancer Res. 3:277–285.
   PubMed Web of Science ®Google Scholar
• Borst, P., and R. O. Elferink. 2002. Mammalian ABC transporters in health and disease. Annu. Rev. Biochem. 71:537–592.
   PubMed Web of Science ®Google Scholar
• Chattopadhyay, R., L. Wiederhold, B. Szczesny, I. Boldogh, T. K. Hazra, T. Izumi, and S. Mitra. 2006. Identification and characterization of mitochondrial abasic (AP)-endonuclease in mammalian cells. Nucleic Acids Res. 34:2067–2076.
   PubMed Web of Science ®Google Scholar
• Chaudhary, P. M., and I. B. Roninson. 1993. Induction of multidrug resistance in human cells by transient exposure to different chemotherapeutic drugs. J. Natl. Cancer Inst. 85:632–639.
   PubMed Web of Science ®Google Scholar
• Clarke, R., S. Currier, O. Kaplan, E. Lovelace, V. Boulay, M. M. Gottesman, and R. B. Dickson. 1992. Effect of P-glycoprotein expression on sensitivity to hormones in MCF-7 human breast cancer cells. J. Natl. Cancer Inst. 84:1506–1512.
   PubMedGoogle Scholar
• Damia, G., L. Imperatori, M. Stefanini, and M. D'Incalci. 1996. Sensitivity of CHO mutant cell lines with specific defects in nucleotide excision repair to different anti-cancer agents. Int. J. Cancer 66:779–783.
   PubMed Web of Science ®Google Scholar
• Daviet, S., S. Couve-Privat, L. Gros, K. Shinozuka, H. Ide, M. Saparbaev, and A. A. Ishchenko. 2007. Major oxidative products of cytosine are substrates for the nucleotide incision repair pathway. DNA Repair (Amsterdam) 6:8–18.
   PubMedGoogle Scholar
• Demple, B., and L. Harrison. 1994. Repair of oxidative damage to DNA: enzymology and biology. Annu. Rev. Biochem. 63:915–948.
   PubMed Web of Science ®Google Scholar
• Evans, A. R., M. Limp-Foster, and M. R. Kelley. 2000. Going APE over ref-1. Mutat. Res. 461:83–108.
   PubMed Web of Science ®Google Scholar
• Fantini, D., C. Vascotto, M. Deganuto, N. Bivi, S. Gustincich, G. Marcon, F. Quadrifoglio, G. Damante, K. K. Bhakat, S. Mitra, and G. Tell. 2008. APE1/Ref-1 regulates PTEN expression mediated by Egr-1. Free Radic. Res. 42:20–29.
   PubMed Web of Science ®Google Scholar
• Freitas, S., D. H. Moore, H. Michael, and M. R. Kelley. 2003. Studies of apurinic/apyrimidinic endonuclease/ref-1 expression in epithelial ovarian cancer: correlations with tumor progression and platinum resistance. Clin. Cancer Res. 9:4689–4694.
   PubMedGoogle Scholar
• Fritz, G., S. Grosch, M. Tomicic, and B. Kaina. 2003. APE/Ref-1 and the mammalian response to genotoxic stress. Toxicology 193:67–78.
   PubMedGoogle Scholar
• Fuchs, S., J. Philippe, P. Corvol, and F. Pinet. 2003. Implication of Ref-1 in the repression of renin gene transcription by intracellular calcium. J. Hypertens. 21:327–335.
   PubMed Web of Science ®Google Scholar
• Fujita, T., K. Ito, H. Izumi, M. Kimura, M. Sano, H. Nakagomi, K. Maeno, Y. Hama, K. Shingu, S. Tsuchiya, K. Kohno, and M. Fujimori. 2005. Increased nuclear localization of transcription factor Y-box binding protein 1 accompanied by up-regulation of P-glycoprotein in breast cancer pretreated with paclitaxel. Clin. Cancer Res. 11:8837–8844.
   PubMed Web of Science ®Google Scholar
• Gao, Z., Z. Gao, J. Z. Fields, and B. M. Boman. 1998. Co-transfection of MDR1 and MRP antisense RNAs abolishes the drug resistance in multidrug-resistant human lung cancer cells. Anticancer Res. 18:3073–3076.
   PubMedGoogle Scholar
• Gottesman, M. M., T. Fojo, and S. E. Bates. 2002. Multidrug resistance in cancer: role of ATP-dependent transporters. Nat. Rev. Cancer 2:48–58.
   PubMed Web of Science ®Google Scholar
• Gros, L., A. A. Ishchenko, H. Ide, R. H. Elder, and M. K. Saparbaev. 2004. The major human AP endonuclease (Ape1) is involved in the nucleotide incision repair pathway. Nucleic Acids Res. 32:73–81.
   PubMedGoogle Scholar
• Hang, B., A. Chenna, H. Fraenkel-Conrat, and B. Singer. 1996. An unusual mechanism for the major human apurinic/apyrimidinic (AP) endonuclease involving 5′ cleavage of DNA containing a benzene-derived exocyclic adduct in the absence of an AP site. Proc. Natl. Acad. Sci. USA 93:13737–13741.
   PubMed Web of Science ®Google Scholar
• Higashi, K., Y. Inagaki, K. Fujimori, A. Nakao, H. Kaneko, and I. Nakatsuka. 2003. Interferon-gamma interferes with transforming growth factor-beta signaling through direct interaction of YB-1 with Smad3. J. Biol. Chem. 278:43470–43479.
   PubMed Web of Science ®Google Scholar
• Higashi, K., Y. Inagaki, N. Suzuki, S. Mitsui, A. Mauviel, H. Kaneko, and I. Nakatsuka. 2003. Y-box-binding protein YB-1 mediates transcriptional repression of human alpha 2(I) collagen gene expression by interferon-gamma. J. Biol. Chem. 278:5156–5162.
   PubMedGoogle Scholar
• Horton, J. K., G. Roy, J. T. Piper, B. Van Houten, Y. C. Awasthi, S. Mitra, M. A. Alaoui-Jamali, I. Boldogh, and S. S. Singhal. 1999. Characterization of a chlorambucil-resistant human ovarian carcinoma cell line overexpressing glutathione S-transferase mu. Biochem. Pharmacol. 58:693–702.
   PubMed Web of Science ®Google Scholar
• Ise, T., G. Nagatani, T. Imamura, K. Kato, H. Takano, M. Nomoto, H. Izumi, H. Ohmori, T. Okamoto, T. Ohga, T. Uchiumi, M. Kuwano, and K. Kohno. 1999. Transcription factor Y-box binding protein 1 binds preferentially to cisplatin-modified DNA and interacts with proliferating cell nuclear antigen. Cancer Res. 59:342–346.
   PubMed Web of Science ®Google Scholar
• Izumi, T., D. B. Brown, C. V. Naidu, K. K. Bhakat, M. A. Macinnes, H. Saito, D. J. Chen, and S. Mitra. 2005. Two essential but distinct functions of the mammalian abasic endonuclease. Proc. Natl. Acad. Sci. USA 102:5739–5743.
   PubMed Web of Science ®Google Scholar
• Izumi, T., and S. Mitra. 1998. Deletion analysis of human AP-endonuclease: minimum sequence required for the endonuclease activity. Carcinogenesis 19:525–527.
   PubMedGoogle Scholar
• Izumi, T., L. R. Wiederhold, G. Roy, R. Roy, A. Jaiswal, K. K. Bhakat, S. Mitra, and T. K. Hazra. 2003. Mammalian DNA base excision repair proteins: their interactions and role in repair of oxidative DNA damage. Toxicology 193:43–65.
   PubMedGoogle Scholar
• Jayaraman, L., N. C. Moorthy, K. G. Murthy, J. L. Manley, M. Bustin, and C. Prives. 1998. High mobility group protein-1 (HMG-1) is a unique activator of p53. Genes Dev. 12:462–472.
   PubMed Web of Science ®Google Scholar
• Jayaraman, L., K. G. Murthy, C. Zhu, T. Curran, S. Xanthoudakis, and C. Prives. 1997. Identification of redox/repair protein Ref-1 as a potent activator of p53. Genes Dev. 11:558–570.
   PubMed Web of Science ®Google Scholar
• Jiang, Y., C. Guo, M. R. Vasko, and M. R. Kelley. 2008. Implications of apurinic/apyrimidinic endonuclease in reactive oxygen signaling response after cisplatin treatment of dorsal root ganglion neurons. Cancer Res. 68:6425–6434.
   PubMed Web of Science ®Google Scholar
• Jin, S., and K. W. Scotto. 1998. Transcriptional regulation of the MDR1 gene by histone acetyltransferase and deacetylase is mediated by NF-Y. Mol. Cell. Biol. 18:4377–4384.
   PubMed Web of Science ®Google Scholar
• Kelley, M. R., L. Cheng, R. Foster, R. Tritt, J. Jiang, J. Broshears, and M. Koch. 2001. Elevated and altered expression of the multifunctional DNA base excision repair and redox enzyme Ape1/ref-1 in prostate cancer. Clin. Cancer Res. 7:824–830.
   PubMed Web of Science ®Google Scholar
• Kohno, K., H. Izumi, T. Uchiumi, M. Ashizuka, and M. Kuwano. 2003. The pleiotropic functions of the Y-box-binding protein, YB-1. Bioessays 25:691–698.
   PubMed Web of Science ®Google Scholar
• Kohno, K., S. Sato, H. Takano, K. Matsuo, and M. Kuwano. 1989. The direct activation of human multidrug resistance gene (MDR1) by anticancer agents. Biochem. Biophys. Res. Commun. 165:1415–1421.
   PubMed Web of Science ®Google Scholar
• Ludwig, D. L., M. A. MacInnes, Y. Takiguchi, P. E. Purtymun, M. Henrie, M. Flannery, J. Meneses, R. A. Pedersen, and D. J. Chen. 1998. A murine AP-endonuclease gene-targeted deficiency with post-implantation embryonic progression and ionizing radiation sensitivity. Mutat. Res. 409:17–29.
   PubMed Web of Science ®Google Scholar
• Marenstein, D. R., M. T. Ocampo, M. K. Chan, A. Altamirano, A. K. Basu, R. J. Boorstein, R. P. Cunningham, and G. W. Teebor. 2001. Stimulation of human endonuclease III by Y box-binding protein 1 (DNA-binding protein B). Interaction between a base excision repair enzyme and a transcription factor. J. Biol. Chem. 276:21242–21249.
   PubMedGoogle Scholar
• Meira, L. B., D. L. Cheo, R. E. Hammer, D. K. Burns, A. Reis, and E. C. Friedberg. 1997. Genetic interaction between HAP1/REF-1 and p53. Nat. Genet. 17:145.
   PubMed Web of Science ®Google Scholar
• Mitra, S., T. Izumi, I. Boldogh, K. K. Bhakat, J. W. Hill, and T. K. Hazra. 2002. Choreography of oxidative damage repair in mammalian genomes. Free Radic. Biol. Med. 33:15–28.
   PubMed Web of Science ®Google Scholar
• Mol, C. D., T. Izumi, S. Mitra, and J. A. Tainer. 2000. DNA-bound structures and mutants reveal abasic DNA binding by APE1 and DNA repair coordination. Nature 403:451–456.
   PubMed Web of Science ®Google Scholar
• Nakshatri, H., P. Bhat-Nakshatri, and R. A. Currie. 1996. Subunit association and DNA binding activity of the heterotrimeric transcription factor NF-Y is regulated by cellular redox. J. Biol. Chem. 271:28784–28791.
   PubMed Web of Science ®Google Scholar
• Oda, Y., A. Sakamoto, N. Shinohara, T. Ohga, T. Uchiumi, K. Kohno, M. Tsuneyoshi, M. Kuwano, and Y. Iwamoto. 1998. Nuclear expression of YB-1 protein correlates with P-glycoprotein expression in human osteosarcoma. Clin. Cancer Res. 4:2273–2277.
   PubMed Web of Science ®Google Scholar
• Ogryzko, V. V., R. L. Schiltz, V. Russanova, B. H. Howard, and Y. Nakatani. 1996. The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 87:953–959.
   PubMed Web of Science ®Google Scholar
• Ohga, T., K. Koike, M. Ono, Y. Makino, Y. Itagaki, M. Tanimoto, M. Kuwano, and K. Kohno. 1996. Role of the human Y box-binding protein YB-1 in cellular sensitivity to the DNA-damaging agents cisplatin, mitomycin C, and ultraviolet light. Cancer Res. 56:4224–4228.
   PubMed Web of Science ®Google Scholar
• Ohga, T., T. Uchiumi, Y. Makino, K. Koike, M. Wada, M. Kuwano, and K. Kohno. 1998. Direct involvement of the Y-box binding protein YB-1 in genotoxic stress-induced activation of the human multidrug resistance 1 gene. J. Biol. Chem. 273:5997–6000.
   PubMed Web of Science ®Google Scholar
• Okamoto, T., H. Izumi, T. Imamura, H. Takano, T. Ise, T. Uchiumi, M. Kuwano, and K. Kohno. 2000. Direct interaction of p53 with the Y-box binding protein, YB-1: a mechanism for regulation of human gene expression. Oncogene 19:6194–6202.
   PubMed Web of Science ®Google Scholar
• Okazaki, T., U. Chung, T. Nishishita, S. Ebisu, S. Usuda, S. Mishiro, S. Xanthoudakis, T. Igarashi, and E. Ogata. 1994. A redox factor protein, ref1, is involved in negative gene regulation by extracellular calcium. J. Biol. Chem. 269:27855–27862.
   PubMedGoogle Scholar
• Puglisi, F., G. Aprile, A. M. Minisini, F. Barbone, P. Cataldi, G. Tell, M. R. Kelley, G. Damante, C. A. Beltrami, and C. Di Loreto. 2001. Prognostic significance of Ape1/ref-1 subcellular localization in non-small cell lung carcinomas. Anticancer Res. 21:4041–4049.
   PubMedGoogle Scholar
• Ramana, C. V., I. Boldogh, T. Izumi, and S. Mitra. 1998. Activation of apurinic/apyrimidinic endonuclease in human cells by reactive oxygen species and its correlation with their adaptive response to genotoxicity of free radicals. Proc. Natl. Acad. Sci. USA 95:5061–5066.
   PubMed Web of Science ®Google Scholar
• Robertson, K. A., H. A. Bullock, Y. Xu, R. Tritt, E. Zimmerman, T. M. Ulbright, R. S. Foster, L. H. Einhorn, and M. R. Kelley. 2001. Altered expression of Ape1/ref-1 in germ cell tumors and overexpression in NT2 cells confers resistance to bleomycin and radiation. Cancer Res. 61:2220–2225.
   PubMedGoogle Scholar
• Robertson, K. A., D. P. Hill, Y. Xu, L. Liu, S. Van Epps, D. M. Hockenbery, J. R. Park, T. M. Wilson, and M. R. Kelley. 1997. Down-regulation of apurinic/apyrimidinic endonuclease expression is associated with the induction of apoptosis in differentiating myeloid leukemia cells. Cell Growth Differ. 8:443–449.
   PubMedGoogle Scholar
• Roy, S., E. Kenny, S. Kennedy, A. Larkin, J. Ballot, M. Perez De Villarreal, J. Crown, and L. O'Driscoll. 2007. MDR1/P-glycoprotein and MRP-1 mRNA and protein expression in non-small cell lung cancer. Anticancer Res. 27:1325–1330.
   PubMed Web of Science ®Google Scholar
• Shibahara, K., T. Uchiumi, T. Fukuda, S. Kura, Y. Tominaga, Y. Maehara, K. Kohno, Y. Nakabeppu, T. Tsuzuki, and M. Kuwano. 2004. Targeted disruption of one allele of the Y-box binding protein-1 (YB-1) gene in mouse embryonic stem cells and increased sensitivity to cisplatin and mitomycin C. Cancer Sci. 95:348–353.
   PubMedGoogle Scholar
• Shimizu, N., K. Sugimoto, J. Tang, T. Nishi, I. Sato, M. Hiramoto, S. Aizawa, M. Hatakeyama, R. Ohba, H. Hatori, T. Yoshikawa, F. Suzuki, A. Oomori, H. Tanaka, H. Kawaguchi, H. Watanabe, and H. Handa. 2000. High-performance affinity beads for identifying drug receptors. Nat. Biotechnol. 18:877–881.
   PubMed Web of Science ®Google Scholar
• Szczesny, B., K. K. Bhakat, S. Mitra, and I. Boldogh. 2004. Age-dependent modulation of DNA repair enzymes by covalent modification and subcellular distribution. Mech. Ageing Dev. 125:755–765.
   PubMed Web of Science ®Google Scholar
• Uchiumi, T., K. Kohno, H. Tanimura, K. Matsuo, S. Sato, Y. Uchida, and M. Kuwano. 1993. Enhanced expression of the human multidrug resistance 1 gene in response to UV light irradiation. Cell Growth Differ. 4:147–157.
   PubMedGoogle Scholar
• Volm, M., R. Koomagi, J. Mattern, and T. Efferth. 2002. Protein expression profiles indicative for drug resistance of non-small cell lung cancer. Br. J. Cancer 87:251–257.
   PubMed Web of Science ®Google Scholar
• Walker, L. J., C. N. Robson, E. Black, D. Gillespie, and I. D. Hickson. 1993. Identification of residues in the human DNA repair enzyme HAP1 (Ref-1) that are essential for redox regulation of Jun DNA binding. Mol. Cell. Biol. 13:5370–5376.
   PubMed Web of Science ®Google Scholar
• Wang, D., M. Luo, and M. R. Kelley. 2004. Human apurinic endonuclease 1 (APE1) expression and prognostic significance in osteosarcoma: enhanced sensitivity of osteosarcoma to DNA damaging agents using silencing RNA APE1 expression inhibition. Mol. Cancer Ther. 3:679–686.
   PubMed Web of Science ®Google Scholar
• Wiederhold, L., J. B. Leppard, P. Kedar, F. Karimi-Busheri, A. Rasouli-Nia, M. Weinfeld, A. E. Tomkinson, T. Izumi, R. Prasad, S. H. Wilson, S. Mitra, and T. K. Hazra. 2004. AP endonuclease-independent DNA base excision repair in human cells. Mol. Cell 15:209–220.
   PubMed Web of Science ®Google Scholar
• Xanthoudakis, S., G. Miao, F. Wang, Y. C. Pan, and T. Curran. 1992. Redox activation of Fos-Jun DNA binding activity is mediated by a DNA repair enzyme. EMBO J. 11:3323–3335.
   PubMed Web of Science ®Google Scholar
• Xanthoudakis, S., R. J. Smeyne, J. D. Wallace, and T. Curran. 1996. The redox/DNA repair protein, Ref-1, is essential for early embryonic development in mice. Proc. Natl. Acad. Sci. USA 93:8919–8923.
   PubMed Web of Science ®Google Scholar
• Xu, Y., D. H. Moore, J. Broshears, L. Liu, T. M. Wilson, and M. R. Kelley. 1997. The apurinic/apyrimidinic endonuclease (APE/ref-1) DNA repair enzyme is elevated in premalignant and malignant cervical cancer. Anticancer Res. 17:3713–3719.
   PubMed Web of Science ®Google Scholar
• Yoo, D. G., Y. J. Song, E. J. Cho, S. K. Lee, J. B. Park, J. H. Yu, S. P. Lim, J. M. Kim, and B. H. Jeon. 2008. Alteration of APE1/ref-1 expression in non-small cell lung cancer: the implications of impaired extracellular superoxide dismutase and catalase antioxidant systems. Lung Cancer 60:277–284.
   PubMed Web of Science ®Google Scholar
• Zaky, A., C. Busso, T. Izumi, R. Chattopadhyay, A. Bassiouny, S. Mitra, and K. K. Bhakat. 2008. Regulation of the human AP-endonuclease (APE1/Ref-1) expression by the tumor suppressor p53 in response to DNA damage. Nucleic Acids Res. 36:1555–1566.
   PubMed Web of Science ®Google Scholar